Search results for: 'cells'

This issue of High-Tech Materials Technology Opportunity Engine (TOE) profiles significant advancements in high-tech materials for various enhanced industrial applications. The featured innovations include Advancing Medicine with On Demand Cell Culture, Asphaltene Conversion for High-performance Carbon Fiber, Lightweight Composite Lattice Structure...

This edition of the Energy & Power Systems (EPS) TOE features information on next generation lithium-ion batteries transforming energy storage solutions. The TOE also covers the innovations on efficient, low-maintenance offshore wind turbine technology. The TOE focuses on emerging innovations in Cadmium Telluride based solar cell materials for next...

This study explores the global immuno-oncology (I-O) markets evolution from 2020 to 2025. An extensive analysis is provided on the growth opportunities envisioned by Frost & Sullivan to help stakeholders leverage their momentum and disrupt the market by offering best-in-class solutions. The study considers oncology agents for which the immune syst...

This edition of the Industrial Bioprocessing TOE features information on advanced production methods for high-performance non-ionic surfactants for industrial use. The TOE also covers the advancements in utilization of biomass to produce high-quality bioethanol. The TOE focuses on novel method for single-cell protein production through advanced gas...

05 Aug 2024  |  Global  |  Technology Research

CGT Research Outlook and Technology Growth Opportunities

CGT Landscape Assessment

Infographics

×

The CGT landscape has evolved extensively over the past decade. More than 80 CGT products have been commercialized globally, with 34 FDA-approved cell and gene therapies in 2023 alone. The rise in product pipelines and clinical success rates has led to the growing demand for the development of new technology platforms, manufacturing capabilities, a...

There are numerous companies developing immunotherapy approaches to treat cancer, autoimmune and several other diseases. Current study describes some of the recent advances in immunotherapy, mostly cancer. These include refined cell therapies, stem cell applications in cancer treatment, monoclonal, polyclonal and bispecific antibodies. Some of exci...

Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...

An integrated digital microscope, in contrast to the traditional optical microscope, displays the image output directly on a monitor instead of an eyepiece. Thus, the sample can be viewed instantly and easily on a desktop, with the user in a comfortable position. The data can also be analyzed and shared with others with ease. This enables rapid ima...

24 Aug 2021  |  North America  |  Market Research

US and EU Biotech Industry VC Investment Growth Opportunities

Future Growth Potential Driven by Next-generation Cell and Gene Platform Technology Powered by AI

Infographics

×

With this research service, Frost & Sullivan provides critical insights into the biotech, and cell and gene therapy (CGT) venture capital (VC) investment trends highlighting the growth opportunities, key countries in the VC environment, and major trends in cell and gene therapy segment. The study also identifies actionable growth opportunities for ...